151 – 160 of 317
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Prophylaxis in von Willebrand disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Prophylaxis in hemophilia
(
- Contribution to journal › Published meeting abstract
-
Mark
Assessment of health-related quality of life in patients with severe haemophilia with reduced bone density
(
- Contribution to journal › Published meeting abstract
-
Mark
Factor VIII light chain mutations and cysteine substitutions predispose for inhibitor development in mild and moderate haemophilia A: first results from the INSIGHT study
(
- Contribution to journal › Published meeting abstract
-
Mark
Mild haemophilia in Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A: the ESPRIT study
2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.29-30(
- Contribution to journal › Published meeting abstract
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
-
Mark
Management of bleedings in carriers
(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of several automated VWF:RCo assays for monitoring of patients treated with VWF/FVIII concentrates: improved performance with a new modified method
(
- Contribution to journal › Published meeting abstract
-
Mark
The combination of Octaplex (R) and Octanate (R) restores thrombin generation capacity in FVIII inhibitor plasma in-vitro
(
- Contribution to journal › Published meeting abstract